KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Debt Ratio (2016 - 2025)

Sarepta Therapeutics has reported Debt Ratio over the past 15 years, most recently at 0.25 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.25 for Q4 2025, down 13.75% from a year ago — trailing twelve months through Dec 2025 was 0.25 (down 13.75% YoY), and the annual figure for FY2025 was 0.25, down 13.75%.
  • Debt Ratio for Q4 2025 was 0.25 at Sarepta Therapeutics, down from 0.31 in the prior quarter.
  • Over the last five years, Debt Ratio for SRPT hit a ceiling of 0.49 in Q4 2022 and a floor of 0.25 in Q4 2025.
  • Median Debt Ratio over the past 5 years was 0.37 (2023), compared with a mean of 0.37.
  • Biggest five-year swings in Debt Ratio: soared 69.05% in 2021 and later dropped 24.34% in 2024.
  • Sarepta Therapeutics' Debt Ratio stood at 0.35 in 2021, then skyrocketed by 41.67% to 0.49 in 2022, then decreased by 23.18% to 0.38 in 2023, then dropped by 24.34% to 0.29 in 2024, then decreased by 13.75% to 0.25 in 2025.
  • The last three reported values for Debt Ratio were 0.25 (Q4 2025), 0.31 (Q3 2025), and 0.31 (Q2 2025) per Business Quant data.